Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer

Thyroid cancer is the most common endocrine malignancy, and many patients with metastatic differentiated thyroid cancer (DTC), poorly differentiated thyroid cancer (PDTC), and anaplastic thyroid cancer (ATC) fail to respond to conventional therapies, resulting in morbidity and mortality. Additional...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular cancer 2014-03, Vol.13 (1), p.62-62
Hauptverfasser:	Morrison, Jennifer A, Pike, Laura A, Sams, Sharon B, Sharma, Vibha, Zhou, Qiong, Severson, Jill J, Tan, Aik-Choon, Wood, William M, Haugen, Bryan R
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Animals Binding sites Blotting, Western Cancer therapies Carrier Proteins - genetics Carrier Proteins - metabolism Cell growth Cell Line, Tumor Diabetes Experiments Gene expression Genes, Tumor Suppressor - physiology Genotype & phenotype Health aspects Heterografts Humans Immunohistochemistry Medical prognosis Medical research Metastasis Mice Oligonucleotide Array Sequence Analysis Proteins Reverse Transcriptase Polymerase Chain Reaction Studies Thermal cycling Thyroid cancer Thyroid gland Thyroid Neoplasms - genetics Thyroid Neoplasms - metabolism Transduction, Genetic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!